The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
EGFR tyrosine kinase inhibitor therapy continuation with high-dose hypofractionated radiotherapy in EGFR-mutated non-small cell lung cancer (NSCLC) patients with oligoprogressive disease.
 
Mariacarmela Santarpia
No Relationships to Disclose
 
Maria Rosaria Valerio
Consulting or Advisory Role - Novartis; Pfizer; Roche
 
Nicolò Borsellino
Consulting or Advisory Role - Novartis; Pfizer; Roche
 
Andrea Girlando
No Relationships to Disclose
 
Gianfranco Mancuso
No Relationships to Disclose
 
Giuseppe Altavilla
No Relationships to Disclose
 
Vittorio Gebbia
Consulting or Advisory Role - Novartis; Pfizer; Roche